Daily Movers: Welcoming Fitbit; BioMarin Soars Again, While Oracle Slumps

Thursday’s market session contained many exciting stock movements.

Gainers

Fitbit Inc (NYSE: FIT) was introduced to the New York Stock Exchange, opening at the price of $30.20, representing a 52 percent spike.

Kroger Co (NYSE: KR) reported earnings that were better-than-expected, although it missed analyst estimates on revenues. Kroger was up about 1 percent.

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) was soaring nearly 8 percent due analyst increased target expectations alongside the positive phase III data.

BioMarin Pharmaceutical Inc (NASDAQ: BMRN) surged 12 percent due to three key factors; good news on the drug associated to the genetic mutation that causes dwarfism, strong analyst support and the NASDAQ  approached an all-time high.

Radius Health Inc (NASDAQ: RDUS) skyrocketed to $60.33, from $51.73 (17 percent increase). The catalyst was the announcement of positive top-line data associated from ACTIVExtend trial results.

Lumenis Ltd. (NASDAQ: LMNS) spiked 13 percent, from $12.68 to $13.69, as the company agreed to be purchased for $14 per share by XIO Group.

Losers

Oracle Corporation (NYSE; ORCL) tanked as much as 8 percent due to disappointing earnings results. The tech giant missed fourth quarter profits by $0.08 along with revenues dropping more than 5 percent.

Rite Aid Corporation (NYSE: RAD) dropped as low as 6 percent due to unsatisfied earnings or $0.02 per share, down from $0.04 per share from last year.

Ensco plc (NYSE: ESV) declined nearly 5 percent on the agreement it made to reduce the rate it charged Total S.A. (NYSE: TOT) due to rising oil prices.

Jabil Circuit, Inc. (NYSE: JBL) declined 7 percent to $22.61 on lower earnings estimates from Deutsche Bank. Deutsche lowered its full-year earnings for JBL from $1.68 to $1.63 after the company reported earnings of $0.49 per share.